CD44 and breast carcinoma: Phenotypically, breast cancer stem-like cells (BCSCs) express high CD44 (cell-surface glycoprotein CD44) and low CD24 (cell-surface glycoprotein CD24) (CD44high/CD24low) and also have increased ALDH1 (aldehyde dehydrogenase 1) activity (identified by ALDEFLUORTM assay, StemCell Technologies) [18,34,35].